SCHEDULE: BlackRock Discloses 5.5% Stake in United States Antimony Corp
Beneficial Ownership Disclosure
BlackRock, Inc. has reported a 5.5% beneficial ownership stake in United States Antimony Corp, holding 6,560,151 common shares as of June 30, 2025.
Summary
- BlackRock, Inc. has filed a Schedule 13G, disclosing beneficial ownership of 6,560,151 shares of Common Stock in United States Antimony Corp.
- This ownership represents 5.5% of the class of securities outstanding.
- BlackRock, Inc. holds sole voting power over 6,480,724 shares and sole dispositive power over 6,560,151 shares.
- The shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of United States Antimony Corp.
- Several BlackRock subsidiaries, including BlackRock Advisors, LLC, BlackRock Fund Advisors, BlackRock Institutional Trust Company, National Association, BlackRock Financial Management, Inc., and BlackRock Investment Management, LLC, beneficially own 5% or greater of the outstanding shares.
Sentiment
Score: 7
Explanation: The filing indicates a significant institutional investment by BlackRock, Inc., suggesting a degree of confidence in the issuer, though it is a routine ownership disclosure and not an endorsement of performance.
Positives
- The disclosure of a significant 5.5% stake by a major institutional investor like BlackRock, Inc. may signal confidence in United States Antimony Corp's long-term prospects, potentially attracting further investor interest.
Future Outlook
This Schedule 13G filing is a disclosure of beneficial ownership and does not contain any forward-looking statements or guidance regarding the future performance or strategic direction of United States Antimony Corp.
Management Comments
- BlackRock, Inc. certifies that the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.
Industry Context
This filing is a routine disclosure of an institutional investment stake by BlackRock, Inc. in United States Antimony Corp. It reflects BlackRock's investment activity rather than providing specific insights into broader industry trends or competitive dynamics within the antimony sector.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional holder like BlackRock, Inc. may influence market perception and investor confidence in United States Antimony Corp.
Key Dates
| Date | Description |
|---|---|
| 04/30/2023 | Date of previously revoked Power of Attorney for BlackRock, Inc. |
| 01/21/2025 | Date of execution for the current Power of Attorney by BlackRock, Inc. |
| 06/30/2025 | Date of event which required the filing of this Schedule 13G statement. |
| 07/17/2025 | Date the Schedule 13G statement was signed by BlackRock, Inc. |
Keywords
United States Antimony Corp, BlackRock, Schedule 13G, beneficial ownership, common stock, institutional investment, antimony
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.